Riociguat deemed suitable for PAH in connective tissue disease

SAN FRANCISCO – Phase III clinical trial experience in using riociguat indicates that the drug is just as safe and effective in treating pulmonary arterial hypertension associated with connective...

Field of Interest: Rheumatology